Bellavere Classification of Autonomic Neuropathy
The Bellavere classification system grades cardiovascular autonomic neuropathy (CAN) into four progressive stages—early, definite, severe, and atypical—based on the number and pattern of abnormal cardiovascular autonomic reflex tests (CARTs), specifically using heart rate tests and orthostatic blood pressure response. 1
Classification Stages
The Bellavere system stratifies CAN severity as follows:
Early CAN (Possible): One abnormal cardiovagal test result (heart rate test), which should be confirmed over time 1
Definite CAN (Confirmed): At least two abnormal cardiovagal test results 1
Severe/Advanced CAN: Presence of orthostatic hypotension in addition to abnormal heart rate test results 1
Atypical: Isolated orthostatic hypotension without heart rate abnormalities (rare presentation) 1
This classification represents progression from early to advanced autonomic involvement rather than the older concept of parasympathetic-to-sympathetic progression 1. Progressive stages correlate with increasingly worse prognosis 1.
Required Autonomic Function Tests
The gold standard CARTs for Bellavere classification include three heart rate tests and one blood pressure test 1:
Heart Rate Tests (Parasympathetic Function)
- Heart rate response to deep breathing: Measures heart rate variability during controlled deep breathing cycles
- Heart rate response to standing (30:15 ratio): Assesses heart rate changes from lying to standing position
- Heart rate response to Valsalva maneuver: Evaluates heart rate changes during forced expiration against closed glottis
Blood Pressure Test (Sympathetic Function)
- Blood pressure response to standing (Orthostatic hypotension test): Measures blood pressure drop upon standing (≥20 mmHg systolic or ≥10 mmHg diastolic defines orthostatic hypotension)
Clinical Application and Diagnostic Accuracy
Recent validation studies demonstrate strong diagnostic performance of Bellavere's Score across different patient populations 2, 3:
- Sensitivity: 75-89% depending on disease stage
- Specificity: 69-96% depending on disease stage
- In CKD stage III: 78.57% sensitivity, 91.4% specificity
- In hemodialysis patients: 79.78% sensitivity, 79.28% specificity 2
The prevalence of CAN using Bellavere criteria ranges from 41-60% in diabetic populations 2, 3, though this may underestimate isolated sympathetic neuropathy compared to other classification systems 4.
Critical Testing Considerations
Pre-Test Requirements
Age-adjusted normative values are strictly required for accurate interpretation 1. Age is the most relevant confounding factor affecting heart rate tests.
Patients must avoid the following before testing 1:
- Caffeine, alcohol, and smoking for at least 2 hours
- Strenuous exercise for 24 hours
- Testing within 2 hours of meals or short-acting insulin
- Testing during hypoglycemia, marked hyperglycemia, fever, infection, or dehydration
Medication washout is essential 1: Diuretics, sympatholytic agents, and psychoactive drugs should be discontinued if possible; otherwise interpret results with caution.
Testing Contraindications
Avoid Valsalva maneuver in patients with proliferative retinopathy or increased risk of retinal hemorrhage 1.
Advantages Over Alternative Systems
Compared to Ewing's criteria (which may leave many patients uncategorized), Bellavere's system provides clearer staging and can identify patients across the full spectrum of autonomic dysfunction 4. However, one limitation is that Bellavere criteria may miss patients with dominant sympathetic neuropathy if only standard CARTs are performed 4.
Clinical Implications
More than one heart rate test plus the orthostatic hypotension test are required for definitive CAN diagnosis and staging 1. A single abnormal test identifies only "possible" CAN requiring confirmation.
The combination of CARTs with sudomotor function tests may provide more accurate diagnosis of diabetic autonomic neuropathy 1, though the core Bellavere classification relies on the four cardiovascular tests described above.